Shanghai Kehua Bio-engineering Co Ltd.
002022
Overview
Corporate Details
- ISIN(s):
- CNE000001KC9
- LEI:
- Country:
- China
- Address:
- N/A
- Website:
- N/A
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Shanghai Kehua Bio-engineering Co Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Shanghai Kehua Bio-engineering Co Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shanghai Kehua Bio-engineering Co Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
United States of America
CRDL
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea
214370
South Korea
214370
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America
CRBU
United States of America
CRBU
Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.
United States of America
CARM
United States of America
CARM
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572
Japan
4572
Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.
United States of America
RNAC
United States of America
RNAC
Develops and commercializes drugs for oncology, transplant, and autoimmune disease.
United States of America
CASI
United States of America
CASI
Advancing therapies for rare neuromuscular and neurological diseases like LEMS.
United States of America
CPRX
United States of America
CPRX
Produces & distributes lab-tested CBD wellness products for people and pets.
United States of America
YCBD
United States of America
YCBD
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America
CDT
United States of America
CDT